Results 81 to 90 of about 3,193 (201)

Incidence of Thromboembolic Events in Oncology Patients Receiving Intraoperative Tranexamic Acid During Orthopedic Surgery: A Retrospective Review at a Comprehensive Cancer Center.

open access: yes, 2020
Despite an abundance of evidence, routine perioperative antifibrinolytics have been avoided in oncology patients due to concern of thrombosis when given to patients with a preexisting hypercoagulable state.
Trona, Nathaniel   +5 more
core   +1 more source

Significant Hyperfibrinolysis in a Patient With Intracardiac Thrombosis: To Give Antifibrinolytics or Not?

open access: yesTransplantation Direct, 2019
. The hemostatic system is a delicate balance between the coagulation, anticoagulation, and fibrinolytic systems and is responsible for preventing both hemorrhage and thrombosis.
Eric R. Simon, MD   +2 more
doaj   +1 more source

Reduction in Requirements for Allogeneic Blood Products: Pharmacologic Methods

open access: yes, 1996
peer reviewedBACKGROUND: Numerous articles describe the reduction of perioperative bleeding by the therapeutic or prophylactic administration of drugs such as prostacyclin, desmopressin, and natural or synthetic antifibrinolytics.
Gary Hartstein   +5 more
core   +1 more source

Using antifibrinolytics in the peripartum period - concern for a hypercoagulable effect?

open access: yes, 2017
INTRODUCTION: Although antifibrinolytic agents are used to prevent and treat hemorrhage, there are concerns about a potential increased risk for peripartum venous thromboembolism.
C.A. Grotegut   +26 more
core   +1 more source

EXPERIENCE WITH MINOR SURGERIES IN PEOPLE WITH HEMOPHILIA A OR B WITH OR WITHOUT INHIBITORS RECEIVING FITUSIRAN

open access: yesHematology, Transfusion and Cell Therapy
Introduction: While non-factor hemophilia therapies are increasingly available, perioperative management data are limited. Fitusiran is an antithrombin (AT) to increase thrombin generation and restore hemostasis in people with hemophilia (PwH) A/B, with ...
Steven PIPE   +17 more
doaj   +1 more source

Antifibrinolytic Drugs (Aminocaproic Acid and Tranexamic Acid): Treatment Perspectives for Dental Surgery

open access: yes, 2015
The purpose of the review was to evaluate the risks and benefits of antifibrinolytic drugs, aminocaproic acid and tranexamic acid, with respect to dental surgery.
Brown, Ronald S.
core   +2 more sources

Does perioperative use of aprotinin reduce the rejection rate in heart transplant recipients?

open access: yes, 2008
Objective: Allograft rejection continues to be one of the most common causes of mortality after heart transplantation. We investigated if perioperative use of antifibrinolytics such as aprotinin and tranexamic acid can decrease the rate of rejection ...
Shuhaiber, Jeffrey H.   +3 more
core   +1 more source

Effect of antifibrinolytic drugs on transfusion requirement and blood loss during orthotopic liver transplantation: Results from a single center

open access: yesAsian Journal of Transfusion Science, 2008
Background: During orthotopic liver transplantation (OLT), activation of the fibrinolytic system can contribute significantly to perioperative bleeding.
Devi A   +4 more
doaj  

Antifibrinolytics and current anaesthetic [PDF]

open access: yesBritish Journal of Anaesthesia, 2014
M H, Davies, S, Jagannathan
openaire   +2 more sources

Home - About - Disclaimer - Privacy